These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 9553097)

  • 1. Crystal structure of the von Willebrand Factor A1 domain and implications for the binding of platelet glycoprotein Ib.
    Emsley J; Cruz M; Handin R; Liddington R
    J Biol Chem; 1998 Apr; 273(17):10396-401. PubMed ID: 9553097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping the glycoprotein Ib-binding site in the von willebrand factor A1 domain.
    Cruz MA; Diacovo TG; Emsley J; Liddington R; Handin RI
    J Biol Chem; 2000 Jun; 275(25):19098-105. PubMed ID: 10764791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new mutation, S1285F, within the A1 loop of von Willebrand factor induces a conformational change in A1 loop with abnormal binding to platelet GPIb and botrocetin causing type 2M von Willebrand disease.
    Stepanian A; Ribba AS; Lavergne JM; Fressinaud E; Juhan-Vague I; Mazurier C; Girma JP; Meyer D
    Br J Haematol; 2003 Feb; 120(4):643-51. PubMed ID: 12588351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of von willebrand factor-binding sites for platelet glycoprotein Ib and botrocetin by charged-to-alanine scanning mutagenesis.
    Matsushita T; Meyer D; Sadler JE
    J Biol Chem; 2000 Apr; 275(15):11044-9. PubMed ID: 10753907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of amino acid residues essential for von Willebrand factor binding to platelet glycoprotein Ib. Charged-to-alanine scanning mutagenesis of the A1 domain of human von Willebrand factor.
    Matsushita T; Sadler JE
    J Biol Chem; 1995 Jun; 270(22):13406-14. PubMed ID: 7539426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular modeling of ligand and mutation sites of the type A domains of human von Willebrand factor and their relevance to von Willebrand's disease.
    Jenkins PV; Pasi KJ; Perkins SJ
    Blood; 1998 Mar; 91(6):2032-44. PubMed ID: 9490688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purified A2 domain of von Willebrand factor binds to the active conformation of von Willebrand factor and blocks the interaction with platelet glycoprotein Ibalpha.
    Martin C; Morales LD; Cruz MA
    J Thromb Haemost; 2007 Jul; 5(7):1363-70. PubMed ID: 17389010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of von Willebrand factor binding to the platelet glycoprotein Ib-IX by a membrane skeleton-dependent inside-out signal.
    Englund GD; Bodnar RJ; Li Z; Ruggeri ZM; Du X
    J Biol Chem; 2001 May; 276(20):16952-9. PubMed ID: 11278380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shielding the front-strand beta 3 of the von Willebrand factor A1 domain inhibits its binding to platelet glycoprotein Ibalpha.
    Bonnefoy A; Yamamoto H; Thys C; Kito M; Vermylen J; Hoylaerts MF
    Blood; 2003 Feb; 101(4):1375-83. PubMed ID: 12393553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant von Willebrand factor Arg578-->Gln. A type IIB von Willebrand disease mutation affects binding to glycoprotein Ib but not to collagen or heparin.
    Randi AM; Jorieux S; Tuley EA; Mazurier C; Sadler JE
    J Biol Chem; 1992 Oct; 267(29):21187-92. PubMed ID: 1400429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A discontinuous autoinhibitory module masks the A1 domain of von Willebrand factor.
    Deng W; Wang Y; Druzak SA; Healey JF; Syed AK; Lollar P; Li R
    J Thromb Haemost; 2017 Sep; 15(9):1867-1877. PubMed ID: 28692141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX.
    Yuan Y; Zhang W; Yan R; Liao Y; Zhao L; Ruan C; Du X; Dai K
    Circ Res; 2009 Dec; 105(12):1177-85. PubMed ID: 19875727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of the A3 domain of human von Willebrand factor: implications for collagen binding.
    Huizinga EG; Martijn van der Plas R; Kroon J; Sixma JJ; Gros P
    Structure; 1997 Sep; 5(9):1147-56. PubMed ID: 9331419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the structure and function of the von Willebrand factor A1 domain using targeted deletions and alanine-scanning mutagenesis.
    Kroner PA; Frey AB
    Biochemistry; 1996 Oct; 35(41):13460-8. PubMed ID: 8873615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of the von Willebrand factor-A1 domain with platelet glycoprotein Ib/IX. The role of glycosylation and disulfide bonding in a monomeric recombinant A1 domain protein.
    Cruz MA; Handin RI; Wise RJ
    J Biol Chem; 1993 Oct; 268(28):21238-45. PubMed ID: 8407961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of von Willebrand factor domain A1 with platelet glycoprotein Ibalpha-(1-289). Slow intrinsic binding kinetics mediate rapid platelet adhesion.
    Miura S; Li CQ; Cao Z; Wang H; Wardell MR; Sadler JE
    J Biol Chem; 2000 Mar; 275(11):7539-46. PubMed ID: 10713059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the amino acid residues of the platelet glycoprotein Ib (GPIb) essential for the von Willebrand factor binding by clustered charged-to-alanine scanning mutagenesis.
    Shimizu A; Matsushita T; Kondo T; Inden Y; Kojima T; Saito H; Hirai M
    J Biol Chem; 2004 Apr; 279(16):16285-94. PubMed ID: 14757772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of von Willebrand factor A1 domain complexed with snake venom, bitiscetin: insight into glycoprotein Ibalpha binding mechanism induced by snake venom proteins.
    Maita N; Nishio K; Nishimoto E; Matsui T; Shikamoto Y; Morita T; Sadler JE; Mizuno H
    J Biol Chem; 2003 Sep; 278(39):37777-81. PubMed ID: 12851390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding site on human von Willebrand factor of bitiscetin, a snake venom-derived platelet aggregation inducer.
    Matsui T; Hamako J; Matsushita T; Nakayama T; Fujimura Y; Titani K
    Biochemistry; 2002 Jun; 41(25):7939-46. PubMed ID: 12069583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-function relationship of the A1 domain of von Willebrand factor.
    Girma JP; Ribba AS; Meyer D
    Thromb Haemost; 1995 Jul; 74(1):156-60. PubMed ID: 8578449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.